![]() ![]() This conference call is being webcast to the public and is completely open to members of the media, Vascular Solutions’ shareholders and other interested parties. You will be hearing presentations today from our Chief Executive Officer, Howard Root and our Chief Financial Officer, James Hennen, and all three of us will be available later during the Q&A portion of this call.īut first, the necessary preamble. Thank you for joining us for Vascular Solutions’ first quarter 2016 conference call. Phil Nalbone, Vice President of Corporate Development at Vascular Solutions. I would now like to turn the conference over to Mr. As a reminder, ladies and gentlemen, this conference is being recorded today, Monday, April 25, 2016. Later we will conduct a question and answer session. At this time all participants are in a listen-only mode. Good afternoon and welcome to Vascular Solutions’ First Quarter Conference Call. Phil Nalbone - Vice President, Corporate Development ( NASDAQ: VASC) Q1 2016 Earnings Conference Call Ap4:30 PM ET OraSure Technologies receives $8.Vascular Solutions, Inc.Teleflex completes $170M Standard Bariatrics acquisition.Johnson & Johnson Vision launches overnight, intraocular lenses.7 innovative digital health offerings to treat diabetes.Olympus launches Thunderbeat surgical energy devices.This robotic capsule could deliver large-protein drugs like insulin.FDA clears Nexpowder endoscopic hemostasis system from Medtronic.How Medtronic designed the next generation of GI bleeding treatment.Align Technology launches AI-powered home monitoring for Invisalign clear teeth aligners.Analysts high on AtriCure following Converge AFib procedure update.FDA clears next-gen deep learning MRI software from GE Healthcare.Invacare receives notice of noncompliance on NYSE share price listing rule.New medical device user fees agreement passes Congress.Vascular Solutions wants the court to find for infringement, willful infringement (and the resulting trebled damages), preliminary and permanent injunctions against further infringement, damages, pre- and post-judgment interest and legal fees.įiled Under: Catheters, Legal News, News Well, Patent Infringement, Vascular Tagged With: Boston Scientific, Minnesota, vascularsolutions Rasmussen asked Nigon about the market size and pricing for the GuideLiner catheter," according to the lawsuit. "On March 21, 2013, Rasmussen contacted VSI’s sales representative for the Minnesota territory, Matt Nigon, wanting to discuss the GuideLiner catheter. The lawsuit alleges infringement of 3 VSI patents, all for "Coaxial Guide Catheter for Interventional Cardiology Procedures." It accuses a former VSI employee named Sam Rasmussen, a senior product manager, of taking the same job with Boston Scientific, where he is "responsible for providing marketing leadership for the launch of the Guidezilla catheter," the lawsuit alleges. We intend to move quickly to stop this violation of our rights." We do not take the initiation of patent litigation lightly, but this is exactly the type of conduct that patents were intended to protect – a small medical device company creating a completely new and innovative product only to be flagrantly violated by a knock-off brazenly marketed by the world’s largest interventional cardiology company. "Virtually every substantive aspect of our GuideLiner product and patents, from the design to the dimensions to even the exact words used in the product’s deployment instructions, has been misappropriated by Boston Scientific and applied to their Guidezilla catheter. ![]() "Boston Scientific’s Guidezilla is 1 of the most blatant plagiarisms of a patented medical device that I have ever encountered," Root said back in May. Now Minneapolis-based Vascular Solutions wants Judge John Tunheim to grant an injunction blocking its larger rival from "making, using, offering for sale, or selling Boston Scientific’s Guidezilla guide extension catheter, or any other guide extension catheter" that allegedly infringes the patents, according to court documents.īoston Scientific has filed a sealed motion opposing the injunction bid, according to the documents. Guidezilla’s design, materials, and dimensions are materially the same as those of GuideLiner and those described and claimed in the patents-in-suit," according to court documents. District Court for Minnesota, alleges that Boston Scientific’s Guidezilla catheter "is a copy of VSI’s GuideLiner catheter. Vascular Solutions sued the Natick, Mass.-based medical device company in May, alleging infringement of guided catheter patents in what Vascular Solutions CEO Howard Root then called "1 of the most blatant plagiarisms of a patented medical device that I have ever encountered." Vascular Solutions (NSDQ: VASC) wants a federal judge to block Boston Scientific (NYSE: BSX) from selling its Guidezilla catheter in a patent infringement lawsuit. ![]()
2 Comments
7/24/2023 02:54:34 am
It is secure while traveling to anywhere in the world that you must update your map for better routs.
Reply
7/3/2024 01:12:30 am
If you purchase the download version you will receive an email as soon as the new map is released with the download instructions and release code. If you purchase the shipped USB version you will receive an email notifying you of your tracking number for your new map update.
Reply
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |